{
  "DOI": "10.1007/s12687-016-0262-8",
  "ISSN": [
    "1868-310X",
    "1868-6001"
  ],
  "URL": "http://dx.doi.org/10.1007/s12687-016-0262-8",
  "alternative-id": [
    "262"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Archibald",
      "given": "Alison D.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Hickerton",
      "given": "Chriselle L.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wake",
      "given": "Samantha A.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Jaques",
      "given": "Alice M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Cohen",
      "given": "Jonathan",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Metcalfe",
      "given": "Sylvia A.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Journal of Community Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2016,
        2,
        3
      ]
    ],
    "date-time": "2016-02-03T04:30:16Z",
    "timestamp": 1454473816000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        8,
        16
      ]
    ],
    "date-time": "2023-08-16T18:40:19Z",
    "timestamp": 1692211219000
  },
  "funder": [
    {
      "name": "Australian Postgraduate Award"
    },
    {
      "name": "Victorian Government's Operational Infrastructure Support Program"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2023,
        10,
        17
      ]
    ],
    "date-time": "2023-10-17T05:53:47Z",
    "timestamp": 1697522027231
  },
  "is-referenced-by-count": 12,
  "issn-type": [
    {
      "type": "print",
      "value": "1868-310X"
    },
    {
      "type": "electronic",
      "value": "1868-6001"
    }
  ],
  "issue": "2",
  "issued": {
    "date-parts": [
      [
        2016,
        2,
        3
      ]
    ]
  },
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2016,
          4
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2016,
            2,
            3
          ]
        ],
        "date-time": "2016-02-03T00:00:00Z",
        "timestamp": 1454457600000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s12687-016-0262-8.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s12687-016-0262-8/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s12687-016-0262-8",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "159-171",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2016,
        2,
        3
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2016,
        2,
        3
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2016,
        4
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1002/ajmg.a.32725",
      "author": "K Acharya",
      "doi-asserted-by": "crossref",
      "first-page": "626",
      "issue": "4",
      "journal-title": "Am J Med Genet A",
      "key": "262_CR1",
      "unstructured": "Acharya K, Ross LF (2009) Fragile X screening: attitudes of genetic health professionals. Am J Med Genet A 149A(4):626–632. doi: 10.1002/ajmg.a.32725",
      "volume": "149A",
      "year": "2009"
    },
    {
      "DOI": "10.1097/AOG.0b013e3181fae884",
      "author": "American College of Obstetricians and Gynecologists Committee on Genetics",
      "doi-asserted-by": "crossref",
      "first-page": "1008",
      "issue": "4",
      "journal-title": "Obstet Gynecol",
      "key": "262_CR2",
      "unstructured": "American College of Obstetricians and Gynecologists Committee on Genetics (2010) ACOG Committee Opinion No. 469: carrier screening for fragile X syndrome. Obstet Gynecol 116(4):1008–1010, 10.1097/AOG0b013e3181fae884",
      "volume": "116",
      "year": "2010"
    },
    {
      "DOI": "10.1111/hex.12009",
      "author": "AG Ames",
      "doi-asserted-by": "crossref",
      "first-page": "69",
      "issue": "1",
      "journal-title": "Health Expect",
      "key": "262_CR3",
      "unstructured": "Ames AG, Jaques A, Ukoumunne OC, Archibald AD, Duncan RE, Emery J, Metcalfe SA (2015) Development of a fragile X syndrome (FXS) knowledge scale: towards a modified multidimensional measure of informed choice for FXS population carrier screening. Health Expect 18(1):69–80. doi: 10.1111/hex.12009",
      "volume": "18",
      "year": "2015"
    },
    {
      "DOI": "10.1007/s10897-006-9049-0",
      "author": "A Anido",
      "doi-asserted-by": "crossref",
      "first-page": "97",
      "issue": "1",
      "journal-title": "J Genet Couns",
      "key": "262_CR4",
      "unstructured": "Anido A, Carlson LM, Sherman SL (2007) Attitudes toward fragile X mutation carrier testing from women identified in a general population survey. J Genet Couns 16(1):97–104. doi: 10.1007/s10897-006-9049-0",
      "volume": "16",
      "year": "2007"
    },
    {
      "DOI": "10.1007/s10897-005-1159-6",
      "author": "A Anido",
      "doi-asserted-by": "crossref",
      "first-page": "295",
      "issue": "4",
      "journal-title": "J Genet Couns",
      "key": "262_CR5",
      "unstructured": "Anido A, Carlson LM, Taft L, Sherman SL (2005) Women’s attitudes toward testing for fragile X carrier status: a qualitative analysis. J Genet Couns 14(4):295–306. doi: 10.1007/s10897-005-1159-6",
      "volume": "14",
      "year": "2005"
    },
    {
      "DOI": "10.1002/ajmg.a.35674",
      "author": "AD Archibald",
      "doi-asserted-by": "crossref",
      "first-page": "48",
      "issue": "1",
      "journal-title": "Am J Med Genet A",
      "key": "262_CR6",
      "unstructured": "Archibald AD, Hickerton CL, Jaques AM, Wake S, Cohen J, Metcalfe SA (2013) “It’s about having the choice”: stakeholder perceptions of population-based genetic carrier screening for fragile X syndrome. Am J Med Genet A 161A(1):48–58. doi: 10.1002/ajmg.a.35674",
      "volume": "161A",
      "year": "2013"
    },
    {
      "DOI": "10.1002/ajmg.a.33122",
      "author": "AD Archibald",
      "doi-asserted-by": "crossref",
      "first-page": "2731",
      "issue": "12",
      "journal-title": "Am J Med Genet A",
      "key": "262_CR7",
      "unstructured": "Archibald AD, Jaques AM, Wake S, Collins VR, Cohen J, Metcalfe SA (2009) “It’s something I need to consider”: decisions about carrier screening for fragile X syndrome in a population of non-pregnant women. Am J Med Genet A 149A(12):2731–2738. doi: 10.1002/ajmg.a.33122",
      "volume": "149A",
      "year": "2009"
    },
    {
      "DOI": "10.1126/scitranslmed.3001756",
      "doi-asserted-by": "crossref",
      "key": "262_CR8",
      "unstructured": "Bell CJ, Dinwiddie DL, Miller NA, Hateley SL, Ganusova EE, Mudge J, Langley RJ, Zhang L, Lee CC, Schilkey FD, Sheth V, Woodward JE, Peckham HE, Schroth GP, Kim RW, Kingsmore SF (2011) Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med 3(65):65ra64. doi: 10.1126/scitranslmed.3001756"
    },
    {
      "DOI": "10.1111/cge.12430",
      "author": "PH Birch",
      "doi-asserted-by": "crossref",
      "first-page": "209",
      "issue": "3",
      "journal-title": "Clin Genet",
      "key": "262_CR9",
      "unstructured": "Birch PH (2015) Interactive e-counselling for genetics pre-test decisions: where are we now? Clin Genet 87(3):209–217. doi: 10.1111/cge.12430",
      "volume": "87",
      "year": "2015"
    },
    {
      "author": "K Charmaz",
      "key": "262_CR10",
      "unstructured": "Charmaz K (2006) Constructing grounded theory: a practical guide through qualitative analysis. Sage, Los Angeles",
      "volume-title": "Constructing grounded theory: a practical guide through qualitative analysis",
      "year": "2006"
    },
    {
      "author": "EW Clayton",
      "first-page": "617",
      "issue": "3",
      "journal-title": "Am J Hum Genet",
      "key": "262_CR11",
      "unstructured": "Clayton EW, Hannig VL, Pfotenhauer JP, Parker RA, Campbell PW 3rd, Phillips JA 3rd (1996) Lack of interest by nonpregnant couples in population-based cystic fibrosis carrier screening. Am J Hum Genet 58(3):617–627",
      "volume": "58",
      "year": "1996"
    },
    {
      "DOI": "10.1111/bioe.12122",
      "author": "A Jong de",
      "doi-asserted-by": "crossref",
      "first-page": "46",
      "issue": "1",
      "journal-title": "Bioethics",
      "key": "262_CR12",
      "unstructured": "de Jong A, de Wert GM (2015) Prenatal screening: an ethical agenda for the near future. Bioethics 29(1):46–55. doi: 10.1111/bioe.12122",
      "volume": "29",
      "year": "2015"
    },
    {
      "DOI": "10.1097/AOG.0000000000000666",
      "doi-asserted-by": "crossref",
      "key": "262_CR13",
      "unstructured": "Edwards JG, Feldman G, Goldberg J, Gregg AR, Norton ME, Rose NC, Schneider A, Stoll K, Wapner R, Watson MS (2015) Expanded carrier screening in reproductive medicine-points to consider: a joint statement of the American College of Medical Genetics and Genomics, American College of Obstetricians and Gynecologists, National Society of Genetic Counselors, Perinatal Quality Foundation, and Society for Maternal-Fetal Medicine. Obstet Gynecol 125(3):653–662. doi: 10.1097/aog.0000000000000666"
    },
    {
      "DOI": "10.1097/01.gim.0000200158.66554.7f",
      "author": "JH Fanos",
      "doi-asserted-by": "crossref",
      "first-page": "129",
      "issue": "2",
      "journal-title": "Genet Med",
      "key": "262_CR14",
      "unstructured": "Fanos JH, Spangner KA, Musci TJ (2006) Attitudes toward prenatal screening and testing for Fragile X. Genet Med 8(2):129–133. doi: 10.1097/01.gim.0000200158.66554.7f",
      "volume": "8",
      "year": "2006"
    },
    {
      "DOI": "10.1007/s10897-012-9524-8",
      "author": "B Finucane",
      "doi-asserted-by": "crossref",
      "first-page": "752",
      "issue": "6",
      "journal-title": "J Genet Couns",
      "key": "262_CR15",
      "unstructured": "Finucane B, Abrams L, Cronister A, Archibald AD, Bennett RL, McConkie-Rosell A (2012) Genetic counseling and testing for FMR1 gene mutations: practice guidelines of the National Society of Genetic Counselors. J Genet Couns 21(6):752–760. doi: 10.1007/s10897-012-9524-8",
      "volume": "21",
      "year": "2012"
    },
    {
      "DOI": "10.1002/ajmg.a.32069",
      "author": "A Frumkin",
      "doi-asserted-by": "crossref",
      "first-page": "264",
      "issue": "2",
      "journal-title": "Am J Med Genet A",
      "key": "262_CR16",
      "unstructured": "Frumkin A, Zlotogora J (2008) Genetic screening for reproductive purposes at school: is it a good strategy? Am J Med Genet A 146A(2):264–269. doi: 10.1002/ajmg.a.32069",
      "volume": "146A",
      "year": "2008"
    },
    {
      "DOI": "10.1038/gim.2013.47",
      "author": "WW Grody",
      "doi-asserted-by": "crossref",
      "first-page": "482",
      "issue": "6",
      "journal-title": "Genet Med",
      "key": "262_CR17",
      "unstructured": "Grody WW, Thompson BH, Gregg AR, Bean LH, Monaghan KG, Lebo RV (2013) ACMG position statement on prenatal/preconception expanded carrier screening. Genet Med 15(6):482–3. doi: 10.1038/gim.2013.47",
      "volume": "15",
      "year": "2013"
    },
    {
      "DOI": "10.1136/jmg.2008.059055",
      "author": "PJ Hagerman",
      "doi-asserted-by": "crossref",
      "first-page": "498",
      "issue": "8",
      "journal-title": "J Med Genet",
      "key": "262_CR18",
      "unstructured": "Hagerman PJ (2008) The fragile X prevalence paradox. J Med Genet 45(8):498–499. doi: 10.1136/jmg.2008.059055",
      "volume": "45",
      "year": "2008"
    },
    {
      "DOI": "10.56021/9780801868436",
      "author": "RJ Hagerman",
      "doi-asserted-by": "crossref",
      "edition": "3",
      "key": "262_CR19",
      "unstructured": "Hagerman RJ, Hagerman PJ (2002) Fragile X syndrome: diagnosis, treatment and research, 3rd edn. The Johns Hopkins University Press, Baltimore",
      "volume-title": "Fragile X syndrome: diagnosis, treatment and research",
      "year": "2002"
    },
    {
      "DOI": "10.1212/WNL.57.1.127",
      "doi-asserted-by": "crossref",
      "key": "262_CR20",
      "unstructured": "Hagerman RJ, Leehey M, Heinrichs W, Tassone F, Wilson R, Hills J, Grigsby J, Gage B, Hagerman PJ (2001) Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 57(1):127–130. doi: 10.1212/WNL.57.1.127"
    },
    {
      "DOI": "10.1097/GIM.0b013e3181fa9fad",
      "author": "FM Hantash",
      "doi-asserted-by": "crossref",
      "first-page": "39",
      "issue": "1",
      "journal-title": "Genet Med",
      "key": "262_CR21",
      "unstructured": "Hantash FM, Goos DM, Crossley B, Anderson B, Zhang K, Sun W, Strom CM (2011) FMR1 premutation carrier frequency in patients undergoing routine population-based carrier screening: insights into the prevalence of fragile X syndrome, fragile X-associated tremor/ataxia syndrome, and fragile X-associated primary ovarian insufficiency in the United States. Genet Med 13(1):39–45. doi: 10.1097/GIM.0b013e3181fa9fad",
      "volume": "13",
      "year": "2011"
    },
    {
      "DOI": "10.1038/ejhg.2015.271",
      "doi-asserted-by": "crossref",
      "key": "262_CR22",
      "unstructured": "Henneman L, Borry P, Chokoshvili D, Cornel MC, van El CG, Forzano F, Hall A, Howard HC, Janssens S, Kayserli H, Lakeman P, Lucassen A, Metcalfe SA, Vidmar L, de Wert G, Dondorp WJ, Peterlin, B on behalf of the European Society of Human Genetics (ESHG) (2016) Responsible implementation of expanded carrier screening. Summary and recommendations of the European Society of Human Genetics. Eur J Hum Genet, In press."
    },
    {
      "DOI": "10.1136/jmg.38.10.695",
      "author": "L Henneman",
      "doi-asserted-by": "crossref",
      "first-page": "695",
      "issue": "10",
      "journal-title": "J Med Genet",
      "key": "262_CR23",
      "unstructured": "Henneman L, Bramsen I, van der Ploeg HM, Ader HJ, van der Horst HE, Gille JJ, ten Kate LP (2001) Participation in preconceptional carrier couple screening: characteristics, attitudes, and knowledge of both partners. J Med Genet 38(10):695–703. doi: 10.1136/jmg.38.10.695",
      "volume": "38",
      "year": "2001"
    },
    {
      "DOI": "10.1089/109065702761403351",
      "author": "L Henneman",
      "doi-asserted-by": "crossref",
      "first-page": "195",
      "issue": "3",
      "journal-title": "Genet Test",
      "key": "262_CR24",
      "unstructured": "Henneman L, Bramsen I, van der Ploeg HM, ten Kate LP (2002) Preconception cystic fibrosis carrier couple screening: impact, understanding, and satisfaction. Genet Test 6(3):195–202. doi: 10.1089/109065702761403351",
      "volume": "6",
      "year": "2002"
    },
    {
      "DOI": "10.1159/000069540",
      "doi-asserted-by": "crossref",
      "key": "262_CR25",
      "unstructured": "Henneman L, Bramsen I, van Kempen L, van Acker MB, Pals G, van der Horst HE, Ader HJ, van der Ploeg HM, ten Kate LP (2003) Offering preconceptional cystic fibrosis carrier couple screening in the absence of established preconceptional care services. Community Genet 6(1):5–13. doi: 10.1159/000069540"
    },
    {
      "DOI": "10.1097/GIM.0b013e3181e38fb6",
      "author": "MK Hill",
      "doi-asserted-by": "crossref",
      "first-page": "396",
      "issue": "7",
      "journal-title": "Genet Med",
      "key": "262_CR26",
      "unstructured": "Hill MK, Archibald AD, Cohen J, Metcalfe SA (2010) A systematic review of population screening for fragile X syndrome. Genet Med 12(7):396–410. doi: 10.1097/GIM.0b013e3181e38fb6",
      "volume": "12",
      "year": "2010"
    },
    {
      "DOI": "10.1002/1096-8628(20000731)93:3\u003c198::AID-AJMG7\u003e3.0.CO;2-Q",
      "author": "M Honnor",
      "doi-asserted-by": "crossref",
      "first-page": "198",
      "issue": "3",
      "journal-title": "Am J Med Genet",
      "key": "262_CR27",
      "unstructured": "Honnor M, Zubrick SR, Walpole I, Bower C, Goldblatt J (2000) Population screening for cystic fibrosis in Western Australia: community response. Am J Med Genet 93(3):198–204. doi: 10.1002/1096-8628(20000731)93:3\u003c198::AID-AJMG7\u003e3.0.CO;2-Q",
      "volume": "93",
      "year": "2000"
    },
    {
      "DOI": "10.1038/gim.2013.125",
      "author": "L Ioannou",
      "doi-asserted-by": "crossref",
      "first-page": "207",
      "issue": "3",
      "journal-title": "Genet Med",
      "key": "262_CR28",
      "unstructured": "Ioannou L, McClaren BJ, Massie J, Lewis S, Metcalfe SA, Forrest L, Delatycki MB (2014) Population-based carrier screening for cystic fibrosis: a systematic review of 23 years of research. Genet Med 16(3):207–216. doi: 10.1038/gim.2013.125",
      "volume": "16",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s10897-007-9099-y",
      "doi-asserted-by": "crossref",
      "key": "262_CR29",
      "unstructured": "McConkie-Rosell A, Abrams L, Finucane B, Cronister A, Gane LW, Coffey SM, Sherman S, Nelson LM, Berry-Kravis E, Hessl D, Chiu S, Street N, Vatave A, Hagerman RJ (2007) Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disorders. J Genet Couns 16(5):593–606. doi: 10.1007/s10897-007-9099-y"
    },
    {
      "DOI": "10.1007/s10897-014-9795-3",
      "author": "KM McWalter",
      "doi-asserted-by": "crossref",
      "first-page": "438",
      "issue": "3",
      "journal-title": "J Genet Couns",
      "key": "262_CR30",
      "unstructured": "McWalter KM, Sdano MR, Dave G, Powell KP, Callanan N (2015) Public health genetic counselors: activities, skills, and sources of learning. J Genet Couns 24(3):438–451. doi: 10.1007/s10897-014-9795-3",
      "volume": "24",
      "year": "2015"
    },
    {
      "DOI": "10.1007/s12687-011-0071-z",
      "author": "SA Metcalfe",
      "doi-asserted-by": "crossref",
      "first-page": "193",
      "issue": "3",
      "journal-title": "J Commun Genet",
      "key": "262_CR31",
      "unstructured": "Metcalfe SA (2012) Carrier screening in preconception consultation in primary care. J Commun Genet 3(3):193–203. doi: 10.1007/s12687-011-0071-z",
      "volume": "3",
      "year": "2012"
    },
    {
      "DOI": "10.1038/gim.2011.79",
      "doi-asserted-by": "crossref",
      "key": "262_CR32",
      "unstructured": "Metcalfe SA, Archibald AD (2012) Fragile X population carrier screening. Genet Med 14(3):350. doi: 10.1038/gim.2011.79 , author reply 351"
    },
    {
      "DOI": "10.1097/GIM.0b013e31817c036e",
      "doi-asserted-by": "crossref",
      "key": "262_CR33",
      "unstructured": "Metcalfe S, Jaques A, Archibald A, Burgess T, Collins V, Henry A, McNamee K, Sheffield L, Slater H, Wake S, Cohen J (2008) A model for offering carrier screening for fragile X syndrome to non-pregnant women: results from a pilot study. Genet Med 10(7):525–535. doi: 10.1097/GIM.0b013e31817c036e"
    },
    {
      "DOI": "10.1159/000078163",
      "author": "FA Poppelaars",
      "doi-asserted-by": "crossref",
      "first-page": "157",
      "issue": "3",
      "journal-title": "Commun Genet",
      "key": "262_CR34",
      "unstructured": "Poppelaars FA, Henneman L, Ader HJ, Cornel MC, Hermens RP, van der Wal G, ten Kate LP (2003) How should preconceptional cystic fibrosis carrier screening be provided? Opinions of potential providers and the target population. Commun Genet 6(3):157–165. doi: 10.1159/000078163",
      "volume": "6",
      "year": "2003"
    },
    {
      "DOI": "10.1038/sj.ejhg.5200285",
      "author": "M Ryynanen",
      "doi-asserted-by": "crossref",
      "first-page": "212",
      "issue": "2",
      "journal-title": "Eur J Hum Genet",
      "key": "262_CR35",
      "unstructured": "Ryynanen M, Heinonen S, Makkonen M, Kajanoja E, Mannermaa A, Pertti K (1999) Feasibility and acceptance of screening for fragile X mutations in low-risk pregnancies. Eur J Hum Genet 7(2):212–216. doi: 10.1038/sj.ejhg.5200285",
      "volume": "7",
      "year": "1999"
    },
    {
      "DOI": "10.1097/01.GIM.0000182468.22666.dd",
      "author": "S Sherman",
      "doi-asserted-by": "crossref",
      "first-page": "584",
      "issue": "8",
      "journal-title": "Genet Med",
      "key": "262_CR36",
      "unstructured": "Sherman S, Pletcher BA, Driscoll DA (2005) Fragile X syndrome: diagnostic and carrier testing. Genet Med 7(8):584–587. doi: 10.1097/01.GIM.0000182468.22666.dd",
      "volume": "7",
      "year": "2005"
    },
    {
      "DOI": "10.1097/01.GIM.0000086480.69309.1E",
      "doi-asserted-by": "crossref",
      "key": "262_CR37",
      "unstructured": "Skinner D, Sparkman KL, Bailey DB Jr (2003) Screening for Fragile X Syndrome: parent attitudes and perspectives. Genet Med 5(5):378–384. doi: 10.1097/01.GIM.0000086480.69309.1E"
    },
    {
      "author": "ES Tambor",
      "first-page": "626",
      "issue": "4",
      "journal-title": "Am J Hum Genet",
      "key": "262_CR38",
      "unstructured": "Tambor ES, Bernhardt BA, Chase GA, Faden RR, Geller G, Hofman KJ, Holtzman NA (1994) Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilization. Am J Hum Genet 55(4):626–637",
      "volume": "55",
      "year": "1994"
    },
    {
      "DOI": "10.1186/gm401",
      "doi-asserted-by": "crossref",
      "key": "262_CR39",
      "unstructured": "Tassone F, Iong KP, Tong T-H, Lo J, Gane LW, Berry-Kravis E, Nguyen D, Mu LY, Laffin J, Bailey D, Hagerman RJ (2012) FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States. Genome Med 4(12):100–100. doi: 10.1186/gm401"
    },
    {
      "DOI": "10.2353/jmoldx.2008.070073",
      "author": "F Tassone",
      "doi-asserted-by": "crossref",
      "first-page": "43",
      "issue": "1",
      "journal-title": "J Mol Diagn",
      "key": "262_CR40",
      "unstructured": "Tassone F, Pan R, Amiri K, Taylor AK, Hagerman PJ (2008) A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations. J Mol Diagn 10(1):43–49. doi: 10.2353/jmoldx.2008.070073",
      "volume": "10",
      "year": "2008"
    },
    {
      "DOI": "10.1007/s12687-014-0204-2",
      "doi-asserted-by": "crossref",
      "key": "262_CR41",
      "unstructured": "Temel S, van Voorst SF, de Jong-Potjer LC, Waelput AJM, Cornel MC, de Weerd SR, Denktas S, Steegers EAP (2015) The Dutch national summit on preconception care: a summary of definitions, evidence and recommendations. J Commun Genet 6(1):107–115. doi: 10.1007/s12687-014-0204-2"
    },
    {
      "DOI": "10.1097/GIM.0b013e318184137c",
      "doi-asserted-by": "crossref",
      "key": "262_CR42",
      "unstructured": "Teutsch SM, Bradley LA, Palomaki GE, Haddow JE, Piper M, Calonge N, Dotson WD, Douglas MP, Berg AO on behalf of the EGAPP Working Group (2009) The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group. Genet Med 11(1):3–14. doi: 10.1097/GIM.0b013e318184137c"
    },
    {
      "DOI": "10.1038/ejhg.2014.32",
      "author": "RV Schendel van",
      "doi-asserted-by": "crossref",
      "first-page": "1345",
      "journal-title": "Eur J Hum Genet",
      "key": "262_CR43",
      "unstructured": "van Schendel RV, Kleinveld JH, Dondorp WJ, Pajkrt E, Timmermans DRM, Holtkamp KCA, Karsten M, Vliestra AL, Lachmeijer AMA, Henneman L (2014) Attitudes of pregnant women and male partners towards non-invasive prenatal testing and widening the scope of prenatal screening. Eur J Hum Genet 22:1345–1350. doi: 10.1038/ejhg.2014.32",
      "volume": "22",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.fertnstert.2006.09.004",
      "doi-asserted-by": "crossref",
      "key": "262_CR44",
      "unstructured": "Wittenberger MD, Hagerman RJ, Sherman SL, McConkie-Rosell A, Welt CK, Rebar RW, Corrigan EC, Simpson JL, Nelson LM (2007) The FMR1 premutation and reproduction. Fertil Steril 87(3):456–465. doi: 10.1016/j.fertnstert.2006.09.004"
    }
  ],
  "reference-count": 44,
  "references-count": 44,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s12687-016-0262-8"
    }
  },
  "score": 0,
  "short-container-title": [
    "J Community Genet"
  ],
  "source": "Crossref",
  "title": [
    "“It gives them more options”: preferences for preconception genetic carrier screening for fragile X syndrome in primary healthcare"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "7"
}